Clinical Trial Update: Tumescent Anesthesia Antibiotic Delivery (TAAD) [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/Phase 3 trial update for a tumescent anesthesia antibiotic delivery approach (TAAD) evaluating surgical site infection and thrombosis outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis
• Surgical Site Infection
• Thrombosis

Drugs mentioned

• Tumescent Anesthesia Antibiotic Delivery (TAAD)

Snippet

Sponsor: HK Surgical, Inc. | Conditions: Surgical Site Infection, Thrombosis | Phase 2, Phase 3 | Status: UNKNOWN